Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery-Reference-Cited by-同舟云学术

Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery

Published:2022-03-07 Issue:2 Volume:54 Page:101-119
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Rachmale Megha¹,Rajput Niraj¹,Jadav Tarang¹,Sahu Amit Kumar¹,Tekade Rakesh K.¹,Sengupta Pinaki¹^ORCID

Affiliation:

1. National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Gandhinagar, Gujarat, India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2022.2048007

Reference119 articles.

1. Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects

2. P-glycoprotein Inhibition: The Past, the Present and the Future

3. Tumor stressors induce two mechanisms of intracellular P-glycoprotein–mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones

4. Alfarouk KO, Stock C-M, Taylor S, Walsh M, Muddathir AK, Verduzco D, Bashir AH, Mohammed OY, Elhassan GO, Harguindey S. 2015. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. 15(1):1–13.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and molecular docking: combined computational approaches to explore the antihypertensive potential of Fabaceae species;Bioresources and Bioprocessing;2024-05-20

2. Toxicological risk assessment and risk management;Public Health and Toxicology Issues Drug Research, Volume 2;2024

3. Implication of sex differences in toxicology;Public Health and Toxicology Issues Drug Research, Volume 2;2024

4. Use of toxicokinetic data in preclinical safety assessment;Public Health and Toxicology Issues Drug Research, Volume 2;2024

5. Design of toxicokinetic studies;Public Health and Toxicology Issues Drug Research, Volume 2;2024